UPDATE 1-Chilean in $13.2 mln insider trading accord with U.S. regulators
October 23, 2015 at 18:30 PM EDT
NEW YORK, Oct 23 (Reuters) - A former board member of Chile's CFR Pharmaceuticals SA has reached a $13.2 million settlement to resolve charges by a U.S. regulator that he engaged in insider trading ahead of Abbott Laboratories' $2.9 billion acquisition of the drug company.
